Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine

Esophageal cancers are highly aggressive tumors with poor prognosis despite some recent advances in surgical and radiochemotherapy treatment options. This study addressed the feasibility of drugs targeting epigenetic modifiers in esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinom...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Epigenetics
Autori principali: Ahrens, Theresa D, Timme, Sylvia, Hoeppner, Jens, Ostendorp, Jenny, Hembach, Sina, Follo, Marie, Hopt, Ulrich T, Werner, Martin, Busch, Hauke, Boerries, Melanie, Lassmann, Silke
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2015
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623041/
https://ncbi.nlm.nih.gov/pubmed/25923331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2015.1039216
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi